Free Trial

PROCEPT BioRobotics (PRCT) News Today

$67.47
+0.72 (+1.08%)
(As of 07/19/2024 ET)
PROCEPT BioRobotics logo with Medical background
Blair William & Co. IL Makes New Investment in PROCEPT BioRobotics Co. (NASDAQ:PRCT)
Blair William & Co. IL acquired a new stake in shares of PROCEPT BioRobotics Co. (NASDAQ:PRCT - Free Report) during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 429,793 shares of the company's stock, valued at approx
PROCEPT BioRobotics logo with Medical background
PROCEPT BioRobotics (NASDAQ:PRCT) Shares Down 6%
PROCEPT BioRobotics (NASDAQ:PRCT) Stock Price Down 6%
PROCEPT BioRobotics logo with Medical background
PROCEPT BioRobotics Co. (NASDAQ:PRCT) Shares Sold by Lisanti Capital Growth LLC
Lisanti Capital Growth LLC reduced its position in PROCEPT BioRobotics Co. (NASDAQ:PRCT - Free Report) by 17.3% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 100,655 shares of the company's stock after se
PROCEPT BioRobotics logo with Medical background
PROCEPT BioRobotics Co. (NASDAQ:PRCT) Receives Average Rating of "Buy" from Analysts
PROCEPT BioRobotics Co. (NASDAQ:PRCT - Get Free Report) has been given a consensus recommendation of "Buy" by the six analysts that are currently covering the firm, MarketBeat reports. Six equities research analysts have rated the stock with a buy rating. The average 12 month price objective among
PROCEPT BioRobotics logo with Medical background
PROCEPT BioRobotics Co. (NASDAQ:PRCT) Shares Sold by Mirae Asset Global Investments Co. Ltd.
Mirae Asset Global Investments Co. Ltd. lessened its holdings in PROCEPT BioRobotics Co. (NASDAQ:PRCT - Free Report) by 21.7% during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 393,540 shares of the company's
PROCEPT BioRobotics logo with Medical background
Vanguard Group Inc. Acquires 109,694 Shares of PROCEPT BioRobotics Co. (NASDAQ:PRCT)
Vanguard Group Inc. lifted its holdings in shares of PROCEPT BioRobotics Co. (NASDAQ:PRCT - Free Report) by 2.7% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 4,184,585 shares of the company's stock after purchasing an ad
PROCEPT BioRobotics logo with Medical background
Wellington Management Group LLP Grows Stock Holdings in PROCEPT BioRobotics Co. (NASDAQ:PRCT)
Wellington Management Group LLP raised its position in shares of PROCEPT BioRobotics Co. (NASDAQ:PRCT - Free Report) by 32.4% in the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 1,065,698 shares of the company's stock after buying an additional 26
PROCEPT BioRobotics Co. (NASDAQ:PRCT) EVP Alaleh Nouri Sells 10,000 Shares
PROCEPT BioRobotics Co. (NASDAQ:PRCT - Get Free Report) EVP Alaleh Nouri sold 10,000 shares of the business's stock in a transaction that occurred on Monday, June 17th. The shares were sold at an average price of $62.18, for a total value of $621,800.00. Following the completion of the transaction, the executive vice president now directly owns 52,472 shares in the company, valued at approximately $3,262,708.96. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website.
PROCEPT BioRobotics Co. (NASDAQ:PRCT) Given Consensus Rating of "Buy" by Analysts
PROCEPT BioRobotics Co. (NASDAQ:PRCT - Get Free Report) has earned a consensus rating of "Buy" from the six analysts that are covering the firm, Marketbeat reports. Six equities research analysts have rated the stock with a buy recommendation. The average twelve-month target price among analysts t
PROCEPT BioRobotics Co. (NASDAQ:PRCT) EVP Hisham Shiblaq Sells 26,046 Shares
PROCEPT BioRobotics Co. (NASDAQ:PRCT - Get Free Report) EVP Hisham Shiblaq sold 26,046 shares of the business's stock in a transaction on Monday, June 10th. The stock was sold at an average price of $68.24, for a total transaction of $1,777,379.04. Following the completion of the transaction, the executive vice president now owns 55,860 shares of the company's stock, valued at approximately $3,811,886.40. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.
Seven Eight Capital LP Makes New Investment in PROCEPT BioRobotics Co. (NASDAQ:PRCT)
Seven Eight Capital LP purchased a new position in shares of PROCEPT BioRobotics Co. (NASDAQ:PRCT - Free Report) in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund purchased 13,128 shares of the company's stock, valued at app
PROCEPT BioRobotics Co. (NASDAQ:PRCT) Shares Acquired by Point72 Europe London LLP
Point72 Europe London LLP raised its stake in shares of PROCEPT BioRobotics Co. (NASDAQ:PRCT - Free Report) by 30.5% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 530,071 shares of the company's stock after acquiring
PEAK6 Investments LLC Buys 28,453 Shares of PROCEPT BioRobotics Co. (NASDAQ:PRCT)
PEAK6 Investments LLC raised its stake in PROCEPT BioRobotics Co. (NASDAQ:PRCT - Free Report) by 163.1% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 45,901 shares of the company's stock after acquiring an additi
Allianz Asset Management GmbH Buys 28,999 Shares of PROCEPT BioRobotics Co. (NASDAQ:PRCT)
Allianz Asset Management GmbH grew its stake in PROCEPT BioRobotics Co. (NASDAQ:PRCT - Free Report) by 42.9% during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 96,635 shares of the company's stock
TD Asset Management Inc Trims Stock Position in PROCEPT BioRobotics Co. (NASDAQ:PRCT)
TD Asset Management Inc lowered its stake in shares of PROCEPT BioRobotics Co. (NASDAQ:PRCT - Free Report) by 17.6% in the fourth quarter, according to its most recent 13F filing with the SEC. The fund owned 214,216 shares of the company's stock after selling 45,600 shares during the period. TD Ass
Rhenman & Partners Asset Management AB Trims Stake in PROCEPT BioRobotics Co. (NASDAQ:PRCT)
Rhenman & Partners Asset Management AB reduced its holdings in shares of PROCEPT BioRobotics Co. (NASDAQ:PRCT - Free Report) by 37.1% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 310,000 shares of the compa
Artisan Partners Limited Partnership Takes Position in PROCEPT BioRobotics Co. (NASDAQ:PRCT)
Artisan Partners Limited Partnership purchased a new position in shares of PROCEPT BioRobotics Co. (NASDAQ:PRCT - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund purchased 370,637 shares of the company
PROCEPT BioRobotics Co. Forecasted to Post Q2 2024 Earnings of ($0.55) Per Share (NASDAQ:PRCT)
PROCEPT BioRobotics Co. (NASDAQ:PRCT - Free Report) - Leerink Partnrs raised their Q2 2024 earnings per share (EPS) estimates for shares of PROCEPT BioRobotics in a research report issued to clients and investors on Tuesday, May 28th. Leerink Partnrs analyst M. Kratky now anticipates that the com
Charles Schwab Investment Management Inc. Purchases 13,868 Shares of PROCEPT BioRobotics Co. (NASDAQ:PRCT)
Charles Schwab Investment Management Inc. grew its position in PROCEPT BioRobotics Co. (NASDAQ:PRCT - Free Report) by 4.3% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 335,117 shares of the compa
PROCEPT BioRobotics Co. (NASDAQ:PRCT) Given Average Rating of "Buy" by Analysts
Shares of PROCEPT BioRobotics Co. (NASDAQ:PRCT - Get Free Report) have been given an average recommendation of "Buy" by the seven brokerages that are covering the stock, MarketBeat Ratings reports. Seven investment analysts have rated the stock with a buy rating. The average 12-month price objecti
PROCEPT BioRobotics Co. (NASDAQ:PRCT) Shares Sold by Massachusetts Financial Services Co. MA
Massachusetts Financial Services Co. MA reduced its holdings in PROCEPT BioRobotics Co. (NASDAQ:PRCT - Free Report) by 15.7% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 571,583 sha
PROCEPT BioRobotics (NASDAQ:PRCT) Hits New 1-Year High at $65.13
PROCEPT BioRobotics (NASDAQ:PRCT) Hits New 12-Month High at $65.13
Victory Capital Management Inc. Has $9.05 Million Holdings in PROCEPT BioRobotics Co. (NASDAQ:PRCT)
Victory Capital Management Inc. decreased its position in shares of PROCEPT BioRobotics Co. (NASDAQ:PRCT - Free Report) by 28.2% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 216,036 shares of the comp
Lisanti Capital Growth LLC Invests $5.10 Million in PROCEPT BioRobotics Co. (NASDAQ:PRCT)
Lisanti Capital Growth LLC acquired a new position in PROCEPT BioRobotics Co. (NASDAQ:PRCT - Free Report) in the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor acquired 121,690 shares of the company's stock, valued at approximately $5,100,000. PR
Unveiling 4 Analyst Insights On PROCEPT BioRobotics
PROCEPT BioRobotics (NASDAQ:PRCT) Given New $75.00 Price Target at TD Cowen
TD Cowen boosted their target price on shares of PROCEPT BioRobotics from $65.00 to $75.00 and gave the stock a "buy" rating in a research note on Monday.
PROCEPT BioRobotics (NASDAQ:PRCT) Shares Down 4.3% Following Insider Selling
PROCEPT BioRobotics (NASDAQ:PRCT) Trading Down 4.3% on Insider Selling
PROCEPT BioRobotics Co. (NASDAQ:PRCT) Director Thomas M. Krummel Sells 20,000 Shares of Stock
PROCEPT BioRobotics Co. (NASDAQ:PRCT - Get Free Report) Director Thomas M. Krummel sold 20,000 shares of the firm's stock in a transaction dated Wednesday, May 1st. The shares were sold at an average price of $60.00, for a total transaction of $1,200,000.00. Following the completion of the sale, the director now owns 45,631 shares in the company, valued at $2,737,860. The transaction was disclosed in a document filed with the SEC, which is accessible through this link.
William Blair Equities Analysts Increase Earnings Estimates for PROCEPT BioRobotics Co. (NASDAQ:PRCT)
PROCEPT BioRobotics Co. (NASDAQ:PRCT - Free Report) - Stock analysts at William Blair lifted their Q2 2024 earnings per share (EPS) estimates for shares of PROCEPT BioRobotics in a research note issued to investors on Wednesday, May 1st. William Blair analyst B. Vazquez now expects that the compa
PROCEPT BioRobotics (NASDAQ:PRCT) Posts Quarterly Earnings Results, Beats Expectations By $0.04 EPS
PROCEPT BioRobotics (NASDAQ:PRCT - Get Free Report) released its quarterly earnings data on Wednesday. The company reported ($0.51) earnings per share for the quarter, beating the consensus estimate of ($0.55) by $0.04. The company had revenue of $44.50 million during the quarter, compared to analyst estimates of $41.58 million. PROCEPT BioRobotics had a negative net margin of 77.75% and a negative return on equity of 46.59%. PROCEPT BioRobotics's revenue for the quarter was up 82.4% compared to the same quarter last year. During the same quarter in the previous year, the business posted ($0.63) EPS.
PROCEPT BioRobotics (NASDAQ:PRCT) Price Target Raised to $72.00
Truist Financial raised their price objective on PROCEPT BioRobotics from $63.00 to $72.00 and gave the stock a "buy" rating in a research note on Thursday.
Get PROCEPT BioRobotics News Delivered to You Automatically

Sign up to receive the latest news and ratings for PRCT and its competitors with MarketBeat's FREE daily newsletter.

Nvidia insiders dumping shares (Ad)

All the signs show the AI market is about to reverse. And unless you know what’s really going on in this sector, you could be wiped out. Inside this new expose, you'll discover exactly how the AI crisis will unfold... how you can prepare for it before it's too late... and how you can potentially profit from it, too. Click here to read the new expose, The Big AI Die-Up while you still can.

To see Porter Stansberry's new AI prediction go here now.

PRCT Media Mentions By Week

PRCT Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

PRCT
News Sentiment

0.71

0.78

Average
Medical
News Sentiment

PRCT News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

PRCT Articles
This Week

7

4

PRCT Articles
Average Week

Get PROCEPT BioRobotics News Delivered to You Automatically

Sign up to receive the latest news and ratings for PRCT and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:PRCT) was last updated on 7/19/2024 by MarketBeat.com Staff

From Our Partners